Pruritus and insomnia in hemodialysis patients; association with SF36 quality of life and clinical outcomes

Tayebeh Soleymanian ¹ * , Saba Alidadiani ², Akram Mahdavi ¹

Cited by CrossRef: 3

1- Chang Y, Lee H, Liao Y, Guu T, Guo S, Hasan F, Jan Y, Lee H, Chiu H. Psychometric and structural properties of the traditional Chinese version of the sleep condition indicator for patients undergoing hemodialysis. Sleep Breath. 2024;28(5):2197 [Crossref]

2- Bai L, Shi J, Du X. Patient-Reported Outcome Measures in CKD-Associated Pruritus: A Systematic Review. Kidney Medicine. 2025;7(8):101055 [Crossref]

3- Iritani M, Taniguchi T. Difelikefalin acetate（KORSUVA^Ⓡ IV Injection Syringe for Dialysis） is a prescription medicine used to treat pruritus associated with chronic kidney disease in patients undergoing hemodialysis. DDS. 2025;40(5):421 [Crossref]

4- TÜRKER E, TANRIKULU G. Kronik Böbrek Yetmezliği Hastalarında Kaşıntı Semptomunun Gece Uyku ve Yaşam Kalitesine Etkisi. 2023;56(2):89 [Crossref]

5- Benetou S, Alikari V, Vasilopoulos G, Polikandrioti M, Kalogianni A, Panoutsopoulos G, Toulia G, Leftheriotis D, Gerogianni G. Factors Associated With Insomnia in Patients Undergoing Hemodialysis. 2022; [Crossref]